DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Aristo Bio-Tech And Lifescience Limited — Shareholders meeting

NSE 2 hrs ago·8 Sept 2026, 3:33 pm

Aristo BIO T AND Lifesc L

Aristo Bio-Tech And Lifescience Limited has announced that its Annual General Meeting (AGM) is scheduled for September 30, 2026. This is a standard corporate event where the company’s board presents its annual financial performance and seeks shareholder approval for key resolutions. The meeting provides an opportunity for investors to review the company's operational status and future strategy.

For investors, this update confirms the company's adherence to regulatory compliance and its commitment to transparency. While the specific agenda items for the meeting have not been disclosed yet, shareholders should monitor the company's future announcements for details on the resolutions to be proposed. Keeping an eye on the outcomes of the AGM will be important for understanding the company's upcoming plans and any strategic shifts.